SCHEMBL7076530

SCHEMBL7076530

Nc1ccccc1Nc1ccc(/C(=N/O)c2sccc2Cl)c(Cl)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 12/20 0.53
MAPK13 O15264 10/20 0.53
MAPK12 P53778 10/20 0.53
MAPK11 Q15759 10/20 0.53
MAPT P10636 6/20 0.38
KDM4E B2RXH2 3/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
TP53 P04637 1/20 0.38
APP P05067 1/20 0.38
HPGD P15428 1/20 0.38
ALOX15 P16050 1/20 0.38
SNCA P37840 1/20 0.38
BLM P54132 1/20 0.38
HSD17B10 Q99714 1/20 0.38
GAA P10253 5/20 0.36
ALDH1A1 P00352 4/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
PRSS12 P56730 1/20 0.36
LMNA P02545 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7076531 1.00 MAPK14 (0.53) MAPK14MAPK13MAPK12MAPK11MAPT
SCHEMBL7077163 0.90 MAPK14 (0.58) MAPK14MAPK13MAPK12MAPK11MAPT
SCHEMBL7077166 0.90 MAPK14 (0.58) MAPK14MAPK13MAPK12MAPK11MAPT
SCHEMBL7074437 0.86 MAPK14 (0.54) MAPK14MAPK13MAPK12MAPK11ALDH1A1
SCHEMBL7074441 0.86 MAPK14 (0.54) MAPK14MAPK13MAPK12MAPK11ALDH1A1
SCHEMBL7079257 0.86 MAPK14 (0.51) MAPK14MAPK13MAPK12MAPK11MAPT
SCHEMBL7079255 0.86 MAPK14 (0.51) MAPK14MAPK13MAPK12MAPK11MAPT
SCHEMBL7076728 0.84 MAPK13 (0.45) MAPK14MAPK13MAPK12MAPK11MAPT
SCHEMBL7076724 0.84 MAPK13 (0.45) MAPK14MAPK13MAPK12MAPK11MAPT
SCHEMBL7080344 0.84 MAPK14 (0.68) MAPK14MAPK13MAPK12MAPK11PRSS12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030073832-A1 Novel aminophenyl ketone derivatives LEO PHARMACEUTICAL PRODUCTS LTD. A/S (DK) 2003-04-17 US claimed
US-20030073832-A1 Novel aminophenyl ketone derivatives LEO PHARMACEUTICAL PRODUCTS LTD. A/S (DK) 2003-04-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030073832-A1 Novel aminophenyl ketone derivatives MAPKAPK2, MAP3K2, MAP3K1 MAPK14 28/4885MAPK13 33/4885MAPK12 36/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.